{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:07:50Z","timestamp":1791115670617,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.neuropharm.2012.07.013","type":"journal-article","created":{"date-parts":[[2012,7,16]],"date-time":"2012-07-16T03:46:29Z","timestamp":1342410389000},"page":"268-282","source":"Crossref","is-referenced-by-count":103,"special_numbering":"C","title":["AMPAKINE enhancement of social interaction in the BTBR mouse model of autism"],"prefix":"10.1016","volume":"64","author":[{"given":"J.L.","family":"Silverman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.F.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Karras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.T.","family":"Gastrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.N.","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2012.07.013_bib1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1162\/089892901564289","article-title":"Abnormal processing of social information from faces in autism","volume":"13","author":"Adolphs","year":"2001","journal-title":"J.\u00a0Cogn. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib2","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bbr.2011.10.032","article-title":"Differences in BTBR T+ tf\/J and C57BL\/6J mice on probabilistic reversal learning and stereotyped behaviors","volume":"227","author":"Amodeo","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2174\/138945007780618490","article-title":"Pharmacology of ampakine modulators: from AMPA receptors to synapses and behavior","volume":"8","author":"Arai","year":"2007","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib4","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1098\/rstb.2008.0337","article-title":"Talent in autism: hyper-systemizing, hyper-attention to detail and sensory hypersensitivity","volume":"364","author":"Baron-Cohen","year":"2009","journal-title":"Philos. Trans. R Soc. Lond B Biol. Sci."},{"issue":"2","key":"10.1016\/j.neuropharm.2012.07.013_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.nbd.2012.04.002","article-title":"Ampakines promote spine actin polymerization, long-term potentiation, and learning in a mouse model of Angelman syndrome","volume":"47","author":"Baudry","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib6","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.brainres.2006.01.002","article-title":"Social cognition: a multi level analysis","volume":"1079","author":"Beer","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib7","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s10803-009-0795-3","article-title":"Brief report: IQ split predicts social symptoms and communication abilities in high-functioning children with autism spectrum disorders","volume":"39","author":"Black","year":"2009","journal-title":"J.\u00a0Autism Dev. Disord."},{"issue":"1","key":"10.1016\/j.neuropharm.2012.07.013_bib8","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neubiorev.2011.06.008","article-title":"BTBR T+tf\/J mice: autism-relevant behaviors and reduced fractone-associated heparan sulfate","volume":"36","author":"Blanchard","year":"2011","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbr.2006.09.007","article-title":"Assessing autism-like behavior in mice: variations in social interactions among inbred strains","volume":"176","author":"Bolivar","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/2040-2392-1-15","article-title":"Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in\u00a0synaptic function, social interaction, and social communication","volume":"1","author":"Bozdagi","year":"2010","journal-title":"Mol. Autism"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00213-009-1540-5","article-title":"Reversal of cognitive deficits by an ampakine (CX516) and sertindole in two animal models of schizophrenia\u2013sub-chronic and early postnatal PCP treatment in attentional set-shifting","volume":"206","author":"Broberg","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib12","series-title":"AMPAKine-Mediated Post-Stroke Functional Improvements","author":"Carmichael","year":"2009"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib13","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/01688639308402609","article-title":"Dysfunctional attention in autistic savants","volume":"15","author":"Casey","year":"1993","journal-title":"J.\u00a0Clin. Exp. Neuropsychol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib14","doi-asserted-by":"crossref","first-page":"5829","DOI":"10.1021\/jm040863t","article-title":"An orally bioavailable, functionally selective inverse agonist at the benzodiazepine site of GABAA alpha5 receptors with cognition enhancing properties","volume":"47","author":"Chambers","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2012.07.013_bib113","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.pbb.2010.09.012","article-title":"Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism","volume":"97","author":"Chadman","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2012.07.013_bib114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1517\/17460441.2012.678828","article-title":"New directions in the treatment of autism spectrum disorders from animal model research","volume":"7","author":"Chadman","year":"2012","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib15","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1017\/S0033291710000991","article-title":"IQ in children with autism spectrum disorders: data from the special needs and autism project (SNAP)","volume":"41","author":"Charman","year":"2011","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tics.2012.02.007","article-title":"The social motivation theory of autism","volume":"16","author":"Chevallier","year":"2012","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib17","doi-asserted-by":"crossref","first-page":"55R","DOI":"10.1203\/PDR.0b013e318212ec6e","article-title":"The quantitative nature of autistic social impairment","volume":"69","author":"Constantino","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.ijo.0802928","article-title":"Antipsychotic drug-induced weight gain: development of an animal model","volume":"29","author":"Cope","year":"2005","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1017\/S003329170999078X","article-title":"Comparison of social cognitive functioning in schizophrenia and high functioning autism: more convergence than divergence","volume":"40","author":"Couture","year":"2010","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1503\/jpn.100179","article-title":"Systematic review of the neural basis of social cognition in patients with mood disorders","volume":"37","author":"Cusi","year":"2012","journal-title":"J.\u00a0Psychiatry Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/brb3.6","article-title":"Neural bases of gaze and emotion processing in children with autism spectrum disorders","volume":"1","author":"Davies","year":"2011","journal-title":"Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib22","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.tics.2010.06.009","article-title":"Can social interaction constitute social cognition?","volume":"14","author":"De Jaegher","year":"2010","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.bbr.2010.10.033","article-title":"A\u00a0novel social proximity test suggests patterns of social avoidance and gaze aversion-like behavior in BTBR T+ tf\/J mice","volume":"217","author":"Defensor","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib24","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1002\/ar.21318","article-title":"Deconstructing sociability, an autism-relevant phenotype, in mouse models","volume":"294","author":"Fairless","year":"2011","journal-title":"Anat. Rec. (Hoboken)"},{"issue":"Suppl. 10","key":"10.1016\/j.neuropharm.2012.07.013_bib25","first-page":"3","article-title":"Epidemiology of autistic disorder and other pervasive developmental disorders","volume":"66","author":"Fombonne","year":"2005","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev-psych-120710-100449","article-title":"Mechanisms of social cognition","volume":"63","author":"Frith","year":"2012","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib27","series-title":"Autism: Explaining the Enigma","author":"Frith","year":"2003"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib28","doi-asserted-by":"crossref","first-page":"11047","DOI":"10.1073\/pnas.191353298","article-title":"Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter","volume":"98","author":"Gainetdinov","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2010.07104.x","article-title":"Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf\/J mouse social behavior","volume":"116","author":"Gould","year":"2011","journal-title":"J.\u00a0Neurochem."},{"issue":"2","key":"10.1016\/j.neuropharm.2012.07.013_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pnpbp.2012.04.011","article-title":"Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice","volume":"38","author":"Gould","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.resp.2009.02.011","article-title":"Ampakine therapy to counter fentanyl-induced respiratory depression","volume":"168","author":"Greer","year":"2009","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib32","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/brain\/awf079","article-title":"Theory of mind in patients with frontal variant frontotemporal dementia and Alzheimer's disease: theoretical and practical implications","volume":"125","author":"Gregory","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib33","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/978-3-642-21649-7_17","article-title":"Fragile X syndrome and targeted treatment trials","volume":"54","author":"Hagerman","year":"2012","journal-title":"Results Probl. Cell Differ."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1097\/FBP.0b013e328331ba1b","article-title":"The ampakine, Org 26576, bolsters early spatial reference learning and retrieval in the Morris water maze: a subchronic, dose-ranging study in rats","volume":"20","author":"Hamlyn","year":"2009","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib35","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1523\/JNEUROSCI.18-07-02748.1998","article-title":"Facilitative effects of the ampakine CX516 on short-term memory in rats: correlations with hippocampal neuronal activity","volume":"18","author":"Hampson","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib36","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1523\/JNEUROSCI.18-07-02740.1998","article-title":"Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance","volume":"18","author":"Hampson","year":"1998","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib37","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0306-4522(03)00423-8","article-title":"Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion","volume":"121","author":"Hess","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1385\/JMN:18:1-2:151","article-title":"Evaluation of an anxiety-related phenotype in galanin overexpressing transgenic mice","volume":"18","author":"Holmes","year":"2002","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2009.12.048","article-title":"Effects of agents targeting glutamatergic systems on marble-burying behavior","volume":"471","author":"Iijima","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib40","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.neubiorev.2012.02.007","article-title":"Autism as a neural systems disorder: a theory of frontal-posterior underconnectivity","volume":"36","author":"Just","year":"2012","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1101\/lm.653607","article-title":"An analysis of calendar performance in two autistic calendar savants","volume":"14","author":"Kennedy","year":"2007","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib42","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.brainres.2010.11.031","article-title":"Is schizophrenia on the autism spectrum?","volume":"1380","author":"King","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib43","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archpsyc.59.9.809","article-title":"Visual fixation patterns during viewing of naturalistic social situations as predictors of social competence in individuals with autism","volume":"59","author":"Klin","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib44","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1469-7610.2004.00304.x","article-title":"Impaired disengagement of attention in young children with autism","volume":"45","author":"Landry","year":"2004","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib45","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1124\/jpet.103.053694","article-title":"Chronic elevation of brain-derived neurotrophic factor by ampakines","volume":"307","author":"Lauterborn","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib46","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neuroscience.2008.12.018","article-title":"Ampakines cause sustained increases in brain-derived neurotrophic factor signaling at excitatory synapses without changes in AMPA receptor subunit expression","volume":"159","author":"Lauterborn","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib47","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.pbb.2011.02.008","article-title":"Attention-modulating effects of cognitive enhancers","volume":"99","author":"Levin","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib48","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1007\/s00381-007-0316-7","article-title":"Death in consequence of late failure of endoscopic third ventriculostomy","volume":"23","author":"Lipina","year":"2007","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib49","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1038\/sj.npp.1301191","article-title":"The ampakine CX546 restores the prepulse inhibition and latent inhibition deficits in mGluR5-deficient mice","volume":"32","author":"Lipina","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib50","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.concog.2010.09.006","article-title":"The role of the self in mindblindness in autism","volume":"20","author":"Lombardo","year":"2011","journal-title":"Conscious. Cogn."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0896-6273(00)00115-X","article-title":"Autism spectrum disorders","volume":"28","author":"Lord","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib52","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1001\/archgenpsychiatry.2011.148","article-title":"A\u00a0multisite study of the clinical diagnosis of different autism spectrum disorders","volume":"69","author":"Lord","year":"2012","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib53","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.tins.2006.07.007","article-title":"Ampakines and the threefold path to cognitive enhancement","volume":"29","author":"Lynch","year":"2006","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib54","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2007.11.082","article-title":"The substrates of memory: defects, treatments, and enhancement","volume":"585","author":"Lynch","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib55","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pbb.2010.12.024","article-title":"The likelihood of cognitive enhancement","volume":"99","author":"Lynch","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2012.07.013_bib56","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nn935","article-title":"Memory enhancement: the search for mechanism-based drugs","volume":"5","author":"Lynch","year":"2002","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib57","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.coph.2003.09.009","article-title":"AMPA receptor modulators as cognitive enhancers","volume":"4","author":"Lynch","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib58","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2008.03.008","article-title":"Impaired fear memory, altered object memory and modified hippocampal synaptic plasticity in split-brain mice","volume":"1210","author":"MacPherson","year":"2008","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib59","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1601-183X.2007.00330.x","article-title":"Autism-like behavioral phenotypes in BTBR T+tf\/J mice","volume":"7","author":"McFarlane","year":"2008","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib60","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s10803-010-1033-8","article-title":"Patterns of visual attention to faces and objects in autism spectrum disorder","volume":"41","author":"McPartland","year":"2011","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib61","doi-asserted-by":"crossref","first-page":"RC65","DOI":"10.1523\/JNEUROSCI.20-06-j0004.2000","article-title":"Methylphenidate enhances working memory by modulating discrete frontal and parietal lobe regions in the human brain","volume":"20","author":"Mehta","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1025010828304","article-title":"Autism families with a high incidence of alcoholism","volume":"33","author":"Miles","year":"2003","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib63","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.pbb.2008.03.003","article-title":"Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1","volume":"90","author":"Mohler","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib64","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.bbr.2006.07.030","article-title":"Mouse behavioral tasks relevant to autism: phenotypes of 10 inbred strains","volume":"176","author":"Moy","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib65","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1016\/j.bmcl.2011.05.026","article-title":"Benzoxazinones as potent positive allosteric AMPA receptor modulators: part I","volume":"21","author":"Mueller","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib66","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1016\/j.bmcl.2011.07.098","article-title":"Benzotriazinone and benzopyrimidinone derivatives as potent positive allosteric AMPA receptor modulators","volume":"21","author":"Mueller","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib67","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.bmcl.2011.05.024","article-title":"Substituted benzoxazinones as potent positive allosteric AMPA receptor modulators: part II","volume":"21","author":"Mueller","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib68","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1016\/j.bmcl.2011.09.132","article-title":"Benzobistriazinones and related heterocyclic ring systems as potent, orally bioavailable positive allosteric AMPA receptor modulators","volume":"21","author":"Mueller","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib69","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1542\/peds.113.5.e472","article-title":"The genetics of autism","volume":"113","author":"Muhle","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib70","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1601-183X.2004.00071.x","article-title":"Automated apparatus for quantitation of social approach behaviors in mice","volume":"3","author":"Nadler","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib72","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/clpt.2009.194","article-title":"Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia","volume":"87","author":"Oertel","year":"2010","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib73","doi-asserted-by":"crossref","first-page":"10912","DOI":"10.1523\/JNEUROSCI.1869-07.2007","article-title":"Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome","volume":"27","author":"Ogier","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib74","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1601-183X.2010.00659.x","article-title":"Motor and cognitive stereotypies in the BTBR T+tf\/J mouse model of autism","volume":"10","author":"Pearson","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib75","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1196\/annals.1416.007","article-title":"Brain mechanisms for social perception: lessons from autism and typical development","volume":"1145","author":"Pelphrey","year":"2008","journal-title":"Ann. N. Y Acad. Sci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib76","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1093\/brain\/awh404","article-title":"Neural basis of eye gaze processing deficits in autism","volume":"128","author":"Pelphrey","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1037\/0033-2909.121.1.114","article-title":"Social cognition in schizophrenia","volume":"121","author":"Penn","year":"1997","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib78","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.neubiorev.2011.10.008","article-title":"A\u00a0systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders","volume":"36","author":"Philip","year":"2012","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib79","article-title":"Autism spectrum disorder: does neuroimaging support the DSM-5 proposal for a symptom dyad? A systematic review of functional magnetic resonance imaging and diffusion tensor imaging studies","author":"Pina-Camacho","year":"2011","journal-title":"J.\u00a0Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib80","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bbr.2010.06.025","article-title":"Expression of social behaviors of C57BL\/6J versus BTBR inbred mouse strains in the visible burrow system","volume":"214","author":"Pobbe","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib81","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.bbr.2010.08.039","article-title":"General and social anxiety in the BTBR T+ tf\/J mouse strain","volume":"216","author":"Pobbe","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib82","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1371\/journal.pbio.0030299","article-title":"Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates","volume":"3","author":"Porrino","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib83","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1111\/j.1469-7610.1995.tb01351.x","article-title":"Savants, segments, art and autism","volume":"36","author":"Pring","year":"1995","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib84","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0166-4328(97)86040-8","article-title":"Cognitive enhancers in theory and practice: studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease","volume":"83","author":"Robbins","year":"1997","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2012.05.048","article-title":"Intact and impaired executive abilities in the BTBR T+ tf\/J mouse model of autism","author":"Rutz","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib86","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bcp.2009.04.019","article-title":"nAChR agonist-induced cognition enhancement: integration of cognitive and neuronal mechanisms","volume":"78","author":"Sarter","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib87","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11689-010-9068-x","article-title":"The benefit of directly comparing autism and schizophrenia for revealing mechanisms of social cognitive impairment","volume":"3","author":"Sasson","year":"2011","journal-title":"J.\u00a0Neurodev Disord."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib88","doi-asserted-by":"crossref","first-page":"e3067","DOI":"10.1371\/journal.pone.0003067","article-title":"Unusual repertoire of vocalizations in the BTBR T+tf\/J mouse model of autism","volume":"3","author":"Scattoni","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib89","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1601-183X.2010.00623.x","article-title":"Unusual repertoire of vocalizations in adult BTBR T+tf\/J mice during three types of social encounters","volume":"10","author":"Scattoni","year":"2011","journal-title":"Genes Brain Behav."},{"issue":"Suppl.","key":"10.1016\/j.neuropharm.2012.07.013_bib90","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1177\/0883073888003001S11","article-title":"Diagnostic features of autism","volume":"3","author":"Schreibman","year":"1988","journal-title":"J.\u00a0Child. Neurol."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib91","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/npp.2009.201","article-title":"Repetitive self-grooming behavior in the BTBR mouse model of autism is blocked by the mGluR5 antagonist MPEP","volume":"35","author":"Silverman","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib92","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrn2851","article-title":"Behavioural phenotyping assays for mouse models of autism","volume":"11","author":"Silverman","year":"2010","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib93","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.neuroscience.2010.09.059","article-title":"Low stress reactivity and neuroendocrine factors in the BTBR T+tf\/J mouse model of autism","volume":"171","author":"Silverman","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib94","doi-asserted-by":"crossref","first-page":"131ra151","DOI":"10.1126\/scitranslmed.3003501","article-title":"Negative allosteric modulation of the mGluR5 receptor reduces repetitive behaviors and rescues social deficits in mouse models of autism","volume":"4","author":"Silverman","year":"2012","journal-title":"Sci. Transl Med."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib95","doi-asserted-by":"crossref","first-page":"4906","DOI":"10.1073\/pnas.0811228106","article-title":"Up-regulating BDNF with an ampakine rescues synaptic plasticity and memory in Huntington's disease knocking mice","volume":"106","author":"Simmons","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib96","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1016\/j.neuropsychologia.2009.04.019","article-title":"The neural substrates of cognitive control deficits in autism spectrum disorders","volume":"47","author":"Solomon","year":"2009","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib97","series-title":"Characterization of CX1837: a Positive AMPA Receptor Modulator (AMPAKINE\u00ae) with Pro-cognitive Activity","author":"Street","year":"2009"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib98","doi-asserted-by":"crossref","first-page":"e25322","DOI":"10.1371\/journal.pone.0025322","article-title":"Autism spectrum disorders and schizophrenia: meta-analysis of the neural correlates of social cognition","volume":"6","author":"Sugranyes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib99","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/syn.1037","article-title":"Member of the Ampakine class of memory enhancers prolongs the single channel open time of reconstituted AMPA receptors","volume":"40","author":"Suppiramaniam","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib100","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/s00213-002-1250-8","article-title":"Cognitive enhancing effects of modafinil in healthy volunteers","volume":"165","author":"Turner","year":"2003","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib101","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1469-7610.2008.02010.x","article-title":"Autism and autism spectrum disorders: diagnostic issues for the coming decade","volume":"50","author":"Volkmar","year":"2009","journal-title":"J.\u00a0Child. Psychol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2012.07.013_bib102","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.nic.2007.07.007","article-title":"Understanding autism and related disorders: what has imaging taught us?","volume":"17","author":"Williams","year":"2007","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib103","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.rasd.2007.08.005","article-title":"Do individuals with high functioning autism have the IQ profile associated with nonverbal learning disability?","volume":"2","author":"Williams","year":"2008","journal-title":"Res. Autism Spectr. Disord."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1601-183X.2010.00582.x","article-title":"Reduced scent marking and ultrasonic vocalizations in the BTBR T+tf\/J mouse model of autism","volume":"10","author":"Wohr","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/neuro.08.001.2007","article-title":"Social approach behaviors are similar on conventional versus reverse lighting cycles, and in replications across cohorts, in BTBR T+ tf\/J, C57BL\/6J, and vasopressin receptor 1B mutant mice","volume":"1","author":"Yang","year":"2007","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib106","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ijdevneu.2007.09.008","article-title":"Social deficits in BTBR T+tf\/J mice are unchanged by cross-fostering with C57BL\/6J mothers","volume":"25","author":"Yang","year":"2007","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib107","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/j.1460-9568.2009.06714.x","article-title":"Postnatal lesion evidence against a primary role for the corpus callosum in mouse sociability","volume":"29","author":"Yang","year":"2009","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib108","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/aur.163","article-title":"Social peers rescue autism-relevant sociability deficits in adolescent mice","volume":"4","author":"Yang","year":"2011","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib109","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0826s56","article-title":"Automated three-chambered social approach task for mice","author":"Yang","year":"2011","journal-title":"Curr. Protoc. Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2011.12.025","article-title":"Low sociability in BTBR T+tf\/J mice is independent of partner strain","author":"Yang","year":"2012","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib111","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1523\/JNEUROSCI.6107-11.2012","article-title":"Reduced excitatory neurotransmission and mild autism-relevant phenotypes in adolescent shank3 null mutant mice","volume":"32","author":"Yang","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2012.07.013_bib112","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2174\/156720511798192709","article-title":"Effects of the putative cognitive-enhancing ampakine, CX717, on attention and object recognition memory","volume":"8","author":"Zheng","year":"2011","journal-title":"Curr. Alzheimer Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390812003498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T10:55:13Z","timestamp":1617620113000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390812003498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":114,"alternative-id":["S0028390812003498"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2012.07.013","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}